Impact of CYP2D6* 2A, CYP2D6* 4 and CYP3A5* 3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
British Journal of Clinical Pharmacology, 2024
Authors
Researchers on Platform
More by this author
Comparison of Postoperative Inflammation, Oxidative Stress, Pain and Cognitive Impairment in Propofol and Sevoflurane: A Randomized Clinical Trial
Enhanced antitumour efficacy of ferulic acid nanoparticles in combination with doxorubicin–a promising strategy for breast cancer treatment
Repurposing of high-dose N-acetylcysteine as anti-inflammatory, antioxidant and neuroprotective agent in moderate to severe traumatic brain injury patients: a …
The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an …
Comparative study between the effects of high doses of rosuvastatin and atorvastatin on ventricular remodeling in patients with ST-segment elevation myocardial infarction